TCL Archive Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease November 30, 2012
TCL Archive Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied July 17, 1992